Context sidebar

New on this website

07.03.2025

Overview of international authorisation procedures

International collaboration in authorisation procedures

06.03.2025

Batch recall – Zovirax i.v. Pulver zur Herstellung einer Infusionslösung

Rückzug der Charge RR4U bis auf Stufe Detailhandel

06.03.2025

Batch recall – Revozyn RTU 400 mg/ml ad us. vet. lnjektionssuspension für Rinder

Rückruf der Chargen 24F053 und 24B191 bis auf Stufe Detailhandel (Tierarzt)

06.03.2025

Swissmedic Journal

Latest edition
Swissmedic Journal Februar 2025

04.03.2025

IT Service Manager/in (80-100%)

Job advertisement | Abteilung Informatik

04.03.2025

Regulatory Manager (80%)

Job advertisement | Abteilung Komplementär- und Phytoarzneimittel

03.03.2025

Batch recall – Neupogen Amgen 30 Injektionslösung

Rückzug der Chargen 1156153A, 1158385A, 1160604A, 1162803A, 1170575A, 1174093A, und 1177814A bis auf Stufe Grosshandel

01.03.2025

Changes to the Guidance document Authorisation of herbal medicinal products

Content-related clarifications, additions and restructuring of the entire Guidance document

01.03.2025

Changes to the Guidance document “Information on PSUR PBRER submission HMP”

Editorial revision

28.02.2025

Authorisations of human medicinal products with a new active substance and additional indications 2024

46 human medicinal products with new active substances authorised

28.02.2025

New information platform – Questions on delimitation relating to human health

Find out in two short videos and an interactive infographic which authority is responsible for which products – simply explained and clearly presented.

28.02.2025

Summary report on authorisation – Fabhalta®

First authorisation
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page
Newsletter
New on the website

Last modification 01.03.2025

Top of page